Instil Bio (TIL) Change in Accured Expenses (2020 - 2026)

Instil Bio's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $54000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 105.34% year-over-year to $54000.0; the TTM figure through Mar 2026 stood at -$1.3 million (up 66.0% YoY), while the FY2025 annual figure was -$2.3 million, down 23.66% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $54000.0, up from -$771000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $3.2 million in Q3 2022, with the low at -$14.2 million in Q4 2022.
• The 5-year median for Change in Accured Expenses is -$1.0 million (2024), against an average of -$1.6 million.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses plunged 458.3% in 2023, then jumped 1030.99% in 2025.
• Instil Bio's Change in Accured Expenses stood at -$14.2 million in 2022, then jumped by 82.61% to -$2.5 million in 2023, then jumped by 37.67% to -$1.5 million in 2024, then surged by 50.06% to -$771000.0 in 2025, then jumped by 107.0% to $54000.0 in 2026.
• Business Quant data shows TIL's Change in Accured Expenses at $54000.0 in Q1 2026, -$771000.0 in Q4 2025, and $1.6 million in Q3 2025.